Capricor Therapeutics, Inc.CAPRNASDAQ
Loading
Year-over-year operating income growth rate
Percentile
P46
Within normal range
vs 2Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -10.93% |
| Q3 2025 | 5.18% |
| Q2 2025 | -10.95% |
| Q1 2025 | -224.54% |
| Q4 2024 | 40.83% |
| Q3 2024 | -12.24% |
| Q2 2024 | -12.91% |
| Q1 2024 | -701.21% |
| Q4 2023 | 81.33% |
| Q3 2023 | 11.39% |
| Q2 2023 | 5.34% |
| Q1 2023 | -1.47% |
| Q4 2022 | -24.52% |
| Q3 2022 | 11.53% |
| Q2 2022 | 6.51% |
| Q1 2022 | -22.76% |
| Q4 2021 | -47.86% |
| Q3 2021 | 15.12% |
| Q2 2021 | 1.51% |
| Q1 2021 | -23.46% |
| Q4 2020 | -6.81% |
| Q3 2020 | -12.22% |
| Q2 2020 | -65.50% |
| Q1 2020 | -42.08% |
| Q4 2019 | 8.88% |
| Q3 2019 | 21.20% |
| Q2 2019 | 19.20% |
| Q1 2019 | 22.66% |
| Q4 2018 | 20.76% |
| Q3 2018 | -0.22% |
| Q2 2018 | -12.94% |
| Q1 2018 | -12.38% |
| Q4 2017 | -24.34% |
| Q3 2017 | 21.93% |
| Q2 2017 | 5.24% |
| Q1 2017 | -22.42% |
| Q4 2016 | 44.41% |
| Q3 2016 | -13.62% |
| Q2 2016 | -9.52% |
| Q1 2016 | -28.19% |